Articles

Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome

CLIP-Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
CLIP-Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
Center for Pediatrics and Adolescent Medicine, University Medical Center, Freiburg, Germany
Center for Pediatrics and Adolescent Medicine, University Medical Center, Freiburg, Germany
CLIP-Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic;Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
Department of Pathology and Molecular Medicine, University Hospital Motol, Prague, Czech Republic
Department of Pediatrics, Charles University, University Hospital Hradec Králové, Czech Republic
Department of Pediatric Hematology, Children’s University Hospital, Brno, Czech Republic
Department of Pediatrics, Palacky University and University Hospital Olomouc, Czech Republic
Department of Pediatrics, University Hospital Pilsen, Czech Republic
Department of Pediatrics Ostrava, University Hospital Ostrava, Czech Republic
Department of Pediatric Hematology and Oncology, University Hospital Bratislava, Slovakia
CLIP-Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
Centre of Oncocytogenetics, Institute of Clinical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine and General University Hospital and Charles University, Prague, Czech Republic
Department of Pathology, Aarhus University Hospital, Denmark
Department of Pediatric Oncology, Princess Máxima Centre for Paediatric Oncology, Utrecht, the Netherlands
Department of Immunology, Erasmus MC, Rotterdam, the Netherlands
Center for Pediatrics and Adolescent Medicine, University Medical Center, Freiburg, Germany
CLIP-Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
CLIP-Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic;Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
CLIP-Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic;Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
CLIP-Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic;Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
Vol. 101 No. 6 (2016): June, 2016 https://doi.org/10.3324/haematol.2015.137711